Last reviewed · How we verify
gefitinib combined with apatinib
gefitinib combined with apatinib is a Small molecule drug developed by Qilu Pharmaceutical Co., Ltd.. It is currently in Phase 2 development. Also known as: yiruike.
At a glance
| Generic name | gefitinib combined with apatinib |
|---|---|
| Also known as | yiruike |
| Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance (PHASE2)
- Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC (PHASE2)
- Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer (PHASE1)
- A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gefitinib combined with apatinib CI brief — competitive landscape report
- gefitinib combined with apatinib updates RSS · CI watch RSS
- Qilu Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about gefitinib combined with apatinib
What is gefitinib combined with apatinib?
gefitinib combined with apatinib is a Small molecule drug developed by Qilu Pharmaceutical Co., Ltd..
Who makes gefitinib combined with apatinib?
gefitinib combined with apatinib is developed by Qilu Pharmaceutical Co., Ltd. (see full Qilu Pharmaceutical Co., Ltd. pipeline at /company/qilu-pharmaceutical-co-ltd).
Is gefitinib combined with apatinib also known as anything else?
gefitinib combined with apatinib is also known as yiruike.
What development phase is gefitinib combined with apatinib in?
gefitinib combined with apatinib is in Phase 2.
Related
- Manufacturer: Qilu Pharmaceutical Co., Ltd. — full pipeline
- Also known as: yiruike
- Compare: gefitinib combined with apatinib vs similar drugs
- Pricing: gefitinib combined with apatinib cost, discount & access